DUBLIN--(BUSINESS WIRE)--The "Platelet Rich Plasma (PRP) Market Analysis By Product (Pure, Leukocyte-Rich, Leukocyte-Rich Fibrin), By Application (Orthopedics, Cosmetic Surgery, Ophthalmic Surgery, Neurosurgery), And Segment Forecasts, 2014 - 2025" report has been added to Research and Markets' offering.
The global platelet rich plasma market is expected to reach USD 647.1 million by 2025
Growing prevalence of orthopedic diseases and increasing application of PRP in cosmetic surgery is propelling the demand for the market. Platelet-rich plasma has become one of the cutting-edge technologies for a number of medical applications including orthopedics, general surgery, cosmetic surgery, cardiovascular surgery, wound healing, and others.
Platelet rich plasma treatments aid in soft tissue healing and reduce the risk of post and preoperative bleeding. As a result, it is considered as one of the most significant treatment methods for the management of several chronic diseases.
The most enticing fact about this treatment is that the procedure helps in regeneration of ligament and tendon fibers, which can possibly obviate the need for surgery and result in enormous growth of the PRP market during the forecast period.
Key Topics Covered:
1 Research Methodology
2 Executive Summary
3 Platelet Rich Plasma Market Variables, Trends & Scope
4 Platelet Rich Plasma Market: Product Estimates & Trend Analysis
5 Platelet Rich Plasma Market: Application Estimates & Trend Analysis
6 Platelet Rich Plasma Market: Regional Estimates & Trend Analysis, by Product& Application
7 Competitive Landscape
- Arthrex, Inc.
- Terumo BCT, Inc.
- EmCyte Corporation
- DePuy Synthes
- Zimmer Biomet
- Glofinn OY
- Dr. PRP America
For more information about this report visit https://www.researchandmarkets.com/research/hg93th/platelet_rich